Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior

Fig. 8

Gene expression of vWF, CE Cad and CD31 by human endothelial cells exposed to HA particles (a) and CLSM images of cells stained for CD31 (green) and nucleus (red) (b); HA particles: 50 μg/mL. HAp2 decreased the expression of VE Cad and CD31 genes, and affected the immunolabeling of CD31. *Significantly different from control (absence of particles); p ≤ 0.05

Back to article page